RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Joe Ramos to Neoplasm Invasiveness

This is a "connection" page, showing publications Joe Ramos has written about Neoplasm Invasiveness.
Connection Strength

0.261
  1. Sulzmaier FJ, Young-Robbins S, Jiang P, Geerts D, Prechtl AM, Matter ML, Kesari S, Ramos JW. RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics. Oncotarget. 2016 Nov 29; 7(48):79869-79884.
    View in: PubMed
    Score: 0.132
  2. Sulzmaier FJ, Ramos JW. RSK isoforms in cancer cell invasion and metastasis. Cancer Res. 2013 Oct 15; 73(20):6099-105.
    View in: PubMed
    Score: 0.106
  3. Liang Z, Sorribas A, Sulzmaier FJ, Jim?nez JI, Wang X, Sauvage T, Yoshida WY, Wang G, Ramos JW, Williams PG. Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits. J Org Chem. 2011 May 20; 76(10):3635-43.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support